HOME › DRUGS › GALCANEZUMAB
ACTIVE SUBSTANCE / INN

GALCANEZUMAB

Brand name(s): Emgality
EMA LISTED
AUTHORISED
Migraine Disorders
ACTIVE SUBSTANCE
Galcanezumab
REGULATORS
EMA
SPONSORS / MAH
Eli Lilly Nederland B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EmgalityEli Lilly Nederland B.V.Authorised14/11/2018Migraine Disorders

FULL INTELLIGENCE ON GALCANEZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →